Are patients with high-risk polycythemia vera receiving cytoreductive medications? A retrospective analysis of real-world data

Overview of attention for article published in Experimental Hematology & Oncology, July 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#13 of 299)
High Attention Score compared to outputs of the same age (85th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

news: 2 news outlets

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 21 Mendeley

Summary News Dimensions citations

So far, Altmetric has seen 2 news stories from 2 outlets.

Study Summary: Real-World Adherence to Cytoreductive Treatment in Polycythemia Vera Is Low

AJMC, 29 Aug 2018

Paranagama D, Colucci P, Evans KA, Bonafede M, Parasuraman S. Are patients with high-risk polycythemia vera receiving…

Adhering to Cytoreductive Therapy Use May Improve Outcomes in Polycythemia Vera

Oncology Nurse Advisor , 15 Aug 2018

August 15, 2018 Study results indicated that only 42% of patients with high-risk PV and 18.9% with low-risk PV received…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.